METASTATIC PDAC
Clinical trials for METASTATIC PDAC explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PDAC trials appear
Sign up with your email to follow new studies for METASTATIC PDAC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double attack on deadly pancreatic cancer shows promise
Disease control OngoingThis study is testing whether adding a new antibody called HLX22 to an existing treatment (trastuzumab plus chemotherapy) works better for people with a specific type of advanced pancreatic cancer (HER2-positive). It aims to see if this combination can shrink tumors and help pati…
Matched conditions: METASTATIC PDAC
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Experimental drug offered to fight wasting in advanced pancreatic cancer
Symptom relief NO_LONGER_AVAILABLEThis program provided access to an investigational drug called mifomelatide for adults with advanced pancreatic cancer who were experiencing severe, unintentional weight loss (cachexia) and had no other good treatment options for it. Eligible patients received daily injections of…
Matched conditions: METASTATIC PDAC
Sponsor: Endevica Bio • Aim: Symptom relief
Last updated Apr 02, 2026 02:56 UTC